Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/ddr.21666 http://scihub22266oqcxt.onion/10.1002/ddr.21666 32227357!7228332!32227357     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Drug+Dev+Res 2020 ; 81 (5): 541-543 Nephropedia Template TP {{tp|p=32227357|t=2020. COVID-19 treatment by repurposing drugs until the vaccine is in sight |pdf=|usr=}}{{32227357}} gab.com Text COVID-19 treatment by repurposing drugs until the vaccine is in sight JO: Drug Dev Res http://www.kidney.de/pget.php?&tw=1&pmid=32227357 #FOAvip Corona virus disease (COVID-19) has created pandemic in the world as declared by WHO on March 12, 2020. It is a viral disease caused by SARS-CoV 2 virus and has affected large populations in over 120 countries. There is no specific treatment available and management is empirical. Until such time that an effective vaccine is available for COVID-19 viral infection, one can repurpose known therapeutic drug molecules such as angiotensin receptor 2 blocker, a commonly used antihypertensive drug, to control COVID-19 virus from gaining entry into the host cell by blocking the angiotensin receptor. Clinical trials should also be undertaken to use statins, which are lipid-lowering drugs but have anti-inflammatory and immunomodulatory properties to prevent acute lung injury in COVID-19 infection. Twit Text FOAVip COVID-19 treatment by repurposing drugs until the vaccine is in sight ????Drug Dev Res http://www.kidney.de/pget.php?&tw=1&pmid=32227357 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32227357 #FOAvip English Wikipedia <ref>{{Cite pmid|32227357}}</ref> COVID-19 treatment by repurposing drugs until the vaccine is in sight #MMPMID32227357 Phadke M; Saunik S Drug Dev Res 2020[Aug]; 81 (5): 541-543 PMID32227357show ga Corona virus disease (COVID-19) has created pandemic in the world as declared by WHO on March 12, 2020. It is a viral disease caused by SARS-CoV 2 virus and has affected large populations in over 120 countries. There is no specific treatment available and management is empirical. Until such time that an effective vaccine is available for COVID-19 viral infection, one can repurpose known therapeutic drug molecules such as angiotensin receptor 2 blocker, a commonly used antihypertensive drug, to control COVID-19 virus from gaining entry into the host cell by blocking the angiotensin receptor. Clinical trials should also be undertaken to use statins, which are lipid-lowering drugs but have anti-inflammatory and immunomodulatory properties to prevent acute lung injury in COVID-19 infection. |*Drug Repositioning[MESH] |Angiotensin II Type 1 Receptor Blockers/administration & dosage/pharmacology[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Coronavirus Infections/*drug therapy/epidemiology/virology[MESH] |Humans[MESH] |Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage/pharmacology[MESH] |Pandemics[MESH]COVID-19 treatment by repurposing drugs until the vaccine is in sight (epmc).pdf DeepDyve Pubget Overpricing